[BMT-v0] Ympoglag (2025-07-15T21:11Z)
|
17.05.2016
|
19.04.2017
|
12.12.2017
|
17.03.2021
|
21.09.2021
|
24.08.2022
|
05.09.2023
|
21.11.2024
|
17.12.2024
|
02.01.2025
|
30.01.2025
|
04.02.2025
|
05.02.2025
|
11.03.2025
|
12.03.2025
|
13.03.2025
|
14.03.2025
|
26.03.2025
|
15.04.2025
|
24.04.2025
|
08.05.2025
|
12.05.2025
|
21.05.2025
|
26.06.2025
|
30.06.2025
|
11.07.2025
|
Meta:Event
|
|
Begann eine 6-monatige Behandlung mit 1.25 mg Finasterid.
|
|
|
|
|
1te COVID-19 Infektion.
|
2te COVID-19 Infektion.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Meta:Alter
|
28 Jahre
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
37 Jahre
|
|
Meta:Gewicht
|
64 kg
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
66.3 kg
|
|
Meta:Symptome
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hohe Symptombelastung. Juckende Haut/Kopfhaut, Muskelzuckungen, Kribbeln in HĂ€nden & FĂŒĂen, Tinnitus.
|
|
|
|
|
|
|
|
|
|
Normale Symptomlast (weder groĂartig noch besonders Schlecht fĂŒr meine VerhĂ€ltnisse).
|
Autoimmundiagnostik:ASLO
|
156 U/ml [<200]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
77 IU/ml [< 200]
|
|
|
|
|
|
Autoimmundiagnostik:AntinukleÀre Antikörper
|
|
|
|
|
|
|
|
|
|
|
|
|
0.1 Ratio [< 1.0]
|
|
|
|
|
0.1 Ratio (?) [{'negativ': '<1.0', 'grenzwertig': '1.0-1.1', 'positiv': '>1.1'}]
|
|
|
0.1 Ratio [< 1.0]
|
|
|
|
|
|
Autoimmundiagnostik:CCP AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<8.0 U/ml [7.0 - 16]
|
|
|
|
|
|
Autoimmundiagnostik:CENP-B AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ [negativ]
|
|
|
|
|
|
|
|
|
Autoimmundiagnostik:Jo-1 AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ [negativ]
|
|
|
|
|
|
|
|
|
Autoimmundiagnostik:MPO-AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.2 IU/ml [< 3.5]
|
|
|
|
|
|
Autoimmundiagnostik:PR3-AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<0.6 IU/ml [< 2.0]
|
|
|
|
|
|
Autoimmundiagnostik:Rheumafaktor
|
10 IU/ml [<15]
|
|
|
|
|
|
|
|
|
|
|
|
<10 IU/ml [< 14]
|
|
|
|
|
|
|
|
<10 IU/ml [< 14]
|
|
|
|
|
|
Autoimmundiagnostik:SS-A/Ro AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ [negativ]
|
|
|
|
|
|
|
|
|
Autoimmundiagnostik:SS-B/La AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ [negativ]
|
|
|
|
|
|
|
|
|
Autoimmundiagnostik:Scl-70 AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ [negativ]
|
|
|
|
|
|
|
|
|
Autoimmundiagnostik:SmD AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ [negativ]
|
|
|
|
|
|
|
|
|
Autoimmundiagnostik:dsDNA AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ IU/ml (!) [{'negativ': '<10', 'grenzwertig': '10-15', 'positiv': '>15'}]
|
|
|
|
|
|
|
|
|
Autoimmundiagnostik:u1RNP AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ [negativ]
|
|
|
|
|
|
|
|
|
Ejakulatkultur:Detritus_und_Fibrin
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
++
|
|
|
|
|
Ejakulatkultur:Kultur_aerob
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wachstum
|
|
|
|
|
Ejakulatkultur:Kultur_anaerob
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
kein Wachstum
|
|
|
|
|
Ejakulatkultur:Molekularer_Erregernachweis:Chlamydia_trachomatis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ
|
|
|
|
|
Ejakulatkultur:Molekularer_Erregernachweis:Neisseria_gonorrhoeae (molekular)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ
|
|
|
|
|
Ejakulatkultur:Mycoplasma_hominis/Ureaplasma_spp
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
nicht nachgewiesen
|
|
|
|
|
Ejakulatkultur:Nachgewiesene_Erreger:Koagulasenegative_Staphylokokken
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
+++
|
|
|
|
|
Ejakulatkultur:Neisseria_gonorrhoeae (kulturell)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
nicht nachgewiesen
|
|
|
|
|
Ejakulatkultur:Sprosspilze
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
nicht nachgewiesen
|
|
|
|
|
Gerinnung:Fibrinogen
|
|
|
|
|
|
|
|
|
|
|
|
|
246 mg/dl [180 - 350]
|
|
309 mg/dl [180 - 350]
|
|
|
|
|
|
|
|
|
|
|
|
Gerinnung:Fibrinogen - Clauss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
353 mg/dL [200 - 400]
|
|
|
|
|
|
|
|
|
|
|
Gerinnung:PTZ
|
|
|
|
|
|
|
|
|
|
|
|
|
119 % [â„ 70]
|
|
113 % [â„ 70]
|
|
|
|
|
|
|
|
|
|
|
|
Gerinnung:Thromboplastinzeit (nach Owren)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
108 % [70 - 125]
|
|
|
|
|
|
|
|
|
|
|
Gerinnung:aPTT
|
|
|
|
|
|
|
|
|
|
|
|
|
28 Sekunden [< 42]
|
|
29 Sekunden [< 42]
|
32.4 s [27.0 - 41.0]
|
|
|
|
|
|
|
|
|
|
|
Hormone:ACTH
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12 pg/ml [4.7 - 49]
|
|
|
|
|
|
|
|
|
|
|
|
Hormone:Androstendion
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.94 ng/ml [0.5 - 3.50]
|
|
|
|
|
|
|
|
|
|
|
|
Hormone:BioverfĂŒgbares Testosteron (BAT)
|
|
|
|
|
2.48 ng/ml [1.1 - 3.1]
|
|
|
|
|
3.45 ng/ml [1.26 - 4.12]
|
3.13 ng/ml [1.26 - 4.12]
|
|
|
|
3.14 ng/ml [1.26 - 4.12]
|
|
|
|
|
|
|
|
3.38 ng/ml [1.26 - 4.12]
|
|
|
|
Hormone:Cortisol
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16.6 ”g/dl [6.0 - 18.4]
|
|
|
|
|
|
|
|
|
|
|
|
Hormone:DHEA-S
|
|
|
|
|
|
|
|
|
|
|
424 ”g/dl [89 - 427]
|
|
|
|
473 ”g/dl (+) [89 - 427]
|
|
|
|
|
|
|
|
|
|
|
|
Hormone:Dihydro-Testosteron
|
|
|
|
|
|
|
|
|
|
|
655 pg/ml [300 - 850]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hormone:FSH
|
|
|
3.3 mIU/ml [1.3 - 19.3]
|
|
2.6 mU/ml [1.5 - 12.4]
|
|
|
|
|
3.0 mIU/ml [1.5 - 12.4]
|
3.7 mIU/ml [1.5 - 12.4]
|
|
|
|
3.9 mIU/ml [1.5 - 12.4]
|
|
|
|
|
|
|
|
4.5 mIU/ml [1.5 - 12.4]
|
|
|
|
Hormone:Freies Testosteron
|
|
|
|
|
|
|
|
|
|
0.151 ng/ml [0.057 - 0.178]
|
0.12 ng/ml [0.057 - 0.178]
|
|
|
|
0.126 ng/ml [0.057 - 0.178]
|
|
|
|
|
|
|
|
0.132 ng/ml [0.057 - 0.178]
|
|
|
|
Hormone:HGH (Somatotropin)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.83 ng/ml [0.05 - 1.23]
|
|
|
|
|
|
|
|
|
|
|
|
Hormone:IGF-1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
210 ng/ml [107 - 239]
|
|
|
|
|
|
|
|
|
|
|
|
Hormone:LH
|
|
|
7.2 mIU/ml [1.2 - 8.6]
|
|
4.9 mU/ml [1.7 - 8.6]
|
|
|
|
|
7.2 mIU/ml [1.7 - 8.6]
|
7.1 mIU/ml [1.7 - 8.6]
|
|
|
|
6.3 mIU/ml [1.7 - 8.6]
|
|
|
|
|
|
|
|
7.2 mIU/ml [1.7 - 8.6]
|
|
|
|
Hormone:Progesteron
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.12 ng/ml [0.00 - 0.15]
|
|
|
|
|
|
|
|
Hormone:Prolaktin
|
|
|
10.4 ng/ml [2.6 - 13.1]
|
|
9.2 ng/ml [4.0 - 15.2]
|
|
|
|
|
9.1 ng/ml [4.0 - 15.2]
|
16.8 ng/ml (+) [4.0 - 15.2]
|
|
|
|
11.0 ng/ml [4.0 - 15.2]
|
|
|
|
|
|
|
|
8.9 ng/ml [4.0 - 15.2]
|
|
|
|
Hormone:SHBG
|
|
|
|
|
61.7 nmol/l (+) [18.3 - 54.1]
|
|
|
|
|
55 nmol/l (+) [18.3 - 54]
|
63 nmol/l (+) [18.3 - 54]
|
|
|
|
64 nmol/l (+) [18.3 - 54]
|
|
|
|
|
|
|
|
67 nmol/l (+) [18.3 - 54]
|
|
|
|
Hormone:SchilddrĂŒse:FT3
|
|
|
|
|
|
3.72 pg/ml [2.0 - 4.4]
|
|
|
3.63 pg/ml [2.15 - 4.12]
|
|
|
|
3.74 pg/ml [2.15 - 4.12]
|
|
3.33 pg/ml [2.15 - 4.12]
|
|
|
|
|
|
|
|
|
|
|
|
Hormone:SchilddrĂŒse:FT4
|
|
|
|
|
|
1.5 ng/dl [0.93 - 1.70]
|
|
|
1.26 ng/dl [0.76 - 1.66]
|
|
|
|
1.2 ng/dl [0.76 - 1.66]
|
|
1.38 ng/dl [0.76 - 1.66]
|
|
|
|
|
|
|
|
|
|
|
|
Hormone:SchilddrĂŒse:TPO-AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<15.0 IU/ml [< 34]
|
|
|
|
|
|
|
|
|
|
|
|
Hormone:SchilddrĂŒse:TSH
|
2.65 ”U/ml [0.30-4.00]
|
|
1.5 ”U/ml [0.38 - 5.33]
|
2.64 ÎŒU/ml [0.27 - 4.20]
|
|
1.49 ”U/ml [0.27 - 4.20]
|
|
|
2.03 ”IU/ml [0.27 - 4.20]
|
|
2.7 ”IU/ml [0.27 - 4.20]
|
1.82 ”IU/ml [0.27 - 4.20]
|
1.92 ”IU/ml [0.27 - 4.20]
|
|
1.55 ”IU/ml [0.27 - 4.20]
|
|
|
|
|
|
|
|
|
|
|
|
Hormone:SchilddrĂŒse:TSH-Rezeptor-AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<1.10 IU/l [0.00 - 1.75]
|
|
|
|
|
|
|
|
|
|
|
|
Hormone:SchilddrĂŒse:Thyreoglobulin-AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17.8 IU/ml [< 115]
|
|
|
|
|
|
|
|
|
|
|
|
Hormone:TSH
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.19 ”IU/ml [0.27 - 4.20]
|
|
|
|
Hormone:Testosteron
|
|
|
9.89 ng/ml (+) [1.75 - 7.81]
|
|
7.25 ng/ml [2.49 - 8.36]
|
|
|
|
|
8.89 ng/ml (+) [2.50 - 8.40]
|
8.48 ng/ml (+) [2.50 - 8.40]
|
|
|
|
8.74 ng/ml (+) [2.50 - 8.40]
|
|
|
|
|
|
|
|
9.46 ng/ml (+) [2.50 - 8.40]
|
|
|
|
Hormone:Ăstradiol
|
|
|
37 pg/ml [0 - 53]
|
|
29.4 pg/ml [8.0 - 43.0]
|
|
|
|
|
41.2 pg/ml [27.1 - 52.2]
|
36.7 pg/ml [27.1 - 52.2]
|
|
|
|
22.2 pg/ml (-) [27.1 - 52.2]
|
|
|
|
|
|
|
|
27.5 pg/ml [27.1 - 52.2]
|
|
|
|
HĂ€matologie:Blutbild:Erythrozyten
|
4.7 T/l [4.4-5.8]
|
|
5.0 T/l [4.2 - 5.5]
|
4.83 T/l [4.4 - 6.0]
|
|
4.67 T/l [4.4 - 5.8]
|
|
|
4.6 T/l [4.4 - 5.8]
|
|
|
4.65 T/l [4.4 - 5.8]
|
4.6 T/l [4.4 - 5.8]
|
4.7 T/l [4.4 - 5.8]
|
4.7 T/l [4.4 - 5.8]
|
4.9 T/L [4.4 - 5.8]
|
|
4.88 T/l [4.4 - 5.8]
|
|
|
4.69 T/l [4.4 - 5.8]
|
|
|
4.49 T/l [4.4 - 5.8]
|
|
|
HĂ€matologie:Blutbild:Erythrozyten-Verteilungsbreite
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12 % [11 - 16]
|
|
|
12 % [11 - 16]
|
|
|
12 % [11 - 16]
|
|
|
12 % [11 - 16]
|
|
|
HĂ€matologie:Blutbild:Erythrozytenverteilungsbreite
|
12 % [11-16]
|
|
|
12.2 % [11.0 - 15.0]
|
|
12 % [11.0 - 16.0]
|
|
|
12 % [11 - 16]
|
|
|
12 % [11 - 16]
|
12 % [11 - 16]
|
12 % [11 - 16]
|
|
11.6 % [11.0 - 16.0]
|
|
|
|
|
|
|
|
|
|
|
HĂ€matologie:Blutbild:HĂ€matokrit
|
42 % [40 - 52]
|
|
45.8 % [42.0 - 51.0]
|
44 % [40 - 52]
|
|
44 % [40 - 52]
|
|
|
42 % [40 - 52]
|
|
|
45 % [40 - 52]
|
44 % [40 - 52]
|
44 % [40 - 52]
|
44 % [40 - 52]
|
44.9 % [40.0 - 52.0]
|
|
46 % [40 - 52]
|
|
|
44 % [40 - 52]
|
|
|
42 % [40 - 52]
|
|
|
HĂ€matologie:Blutbild:HĂ€moglobin
|
13.9 g/dl [13.5-18.0]
|
|
15.0 g/dl [14.0 - 18.0]
|
14.7 g/dl [13.5 - 18.0]
|
|
14.3 g/dl [13.5 - 18.0]
|
|
|
14.5 g/dl [13.5 - 18]
|
|
|
14.6 g/dl [13.5 - 18]
|
14.5 g/dl [13.5 - 18]
|
15.1 g/dl [13.5 - 18]
|
15.0 g/dl [13.5 - 18]
|
15.2 g/dL [13.5 - 18.0]
|
|
15.4 g/dl [13.5 - 18]
|
|
|
14.8 g/dl [13.5 - 18]
|
|
|
14.1 g/dl [13.5 - 18]
|
|
|
HĂ€matologie:Blutbild:Leukozyten
|
6.1 G/l [4.0-10.0]
|
|
6.9 G/l [4.0 - 10.0]
|
7.0 G/l [4.0 - 10.0]
|
|
5.4 G/l [4.0 - 10.0]
|
|
|
6.5 G/l [4.0 - 10.0]
|
|
|
5.9 G/l [4.0 - 10.0]
|
5.7 G/l [4.0 - 10.0]
|
6.1 G/l [4.0 - 10.0]
|
10.8 G/l (+) [4.0 - 10.0]
|
9.27 G/L [4.0 - 10.0]
|
|
8.6 G/l [4.0 - 10.0]
|
|
|
7.7 G/l [4.0 - 10.0]
|
|
|
7.9 G/l [4.0 - 10.0]
|
|
|
HĂ€matologie:Blutbild:MCH
|
30 pg [27-33]
|
|
30 pg [27 - 35]
|
30 pg [27 - 33]
|
|
31 pg [27 - 33]
|
|
|
32 pg [27 - 33]
|
|
|
31 pg [27 - 33]
|
32 pg [27 - 33]
|
32 pg [27 - 33]
|
32 pg [27 - 33]
|
|
|
32 pg [27 - 33]
|
|
|
32 pg [27 - 33]
|
|
|
31 pg [27 - 33]
|
|
|
HĂ€matologie:Blutbild:MCHC
|
33.1 g/dl [32-36]
|
|
33 g/dl [32 - 37]
|
33 g/dl [31 - 36]
|
|
33 g/dl [30 - 36]
|
|
|
35 g/dl [30 - 36]
|
|
|
32 g/dl [30 - 36]
|
33 g/dl [30 - 36]
|
34 g/dl [30 - 36]
|
34 g/dl [30 - 36]
|
|
|
33 g/dl [30 - 36]
|
|
|
34 g/dl [30 - 36]
|
|
|
34 g/dl [30 - 36]
|
|
|
HĂ€matologie:Blutbild:MCV
|
89 fl [78-98]
|
|
93 fl [80 - 100]
|
92 fl [78 - 98]
|
|
94 fl [78 - 98]
|
|
|
91 fl [78 - 98]
|
|
|
97 fl [78 - 98]
|
97 fl [78 - 98]
|
94 fl [78 - 98]
|
93 fl [78 - 98]
|
|
|
95 fl [78 - 98]
|
|
|
93 fl [78 - 98]
|
|
|
93 fl [78 - 98]
|
|
|
HÀmatologie:Blutbild:Mittlere korpuskulÀre HÀmoglobinkonzentration (MCHC)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33.9 g/dL [30.0 - 36.0]
|
|
|
|
|
|
|
|
|
|
|
HĂ€matologie:Blutbild:Mittleres Thrombozytenvolumen
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11.2 fL [7.0 - 13.0]
|
|
|
|
|
|
|
|
|
|
|
HÀmatologie:Blutbild:Mittleres ZellhÀmoglobin (MCH)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.2 pg [27.0 - 33.0]
|
|
|
|
|
|
|
|
|
|
|
HĂ€matologie:Blutbild:Mittleres Zellvolumen (MCV)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
92.2 fL [78.0 - 98.0]
|
|
|
|
|
|
|
|
|
|
|
HĂ€matologie:Blutbild:Normoblasten (NRBC)
|
|
|
0.0 G/l [0.00 - 0.11]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HĂ€matologie:Blutbild:Normoblasten (NRBC) rel.
|
|
|
0.0 /100 Leuko [0.0 - 0.0]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HĂ€matologie:Blutbild:RDW-CV
|
|
|
12.4 % [11.0 - 16.0]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HÀmatologie:Blutbild:Retikulierte PlÀttchen absolut
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20.1 G/L
|
|
|
|
|
|
|
|
|
|
|
HÀmatologie:Blutbild:Retikulierte PlÀttchen relativ
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8.0 % (+) [1 - 6]
|
|
|
|
|
|
|
|
|
|
|
HĂ€matologie:Blutbild:Thrombozyten
|
219 giga/l [150-350]
|
|
242 G/l [150 - 400]
|
226 G/l [150 - 400]
|
|
221 G/l [150 - 350]
|
|
|
246 G/l [150 - 350]
|
|
|
253 G/l [150 - 350]
|
253 G/l [150 - 350]
|
238 G/l [150 - 350]
|
256 G/l [150 - 350]
|
251 G/L [150 - 350]
|
|
291 G/l [150 - 350]
|
|
|
243 G/l [150 - 350]
|
|
|
230 G/l [150 - 350]
|
|
|
HĂ€matologie:Differentialblutbild:Basophile
|
0.1 G/l [<0.2]
|
|
0.1 G/l [0.0 - 0.2]
|
|
|
0.0 G/l [0.0 - 0.1]
|
|
|
0.1 G/l [†0.1]
|
|
|
0.1 G/l [†0.1]
|
0.1 G/l [†0.1]
|
0.1 G/l [†0.1]
|
0.1 G/l [†0.1]
|
0.1 G/l [0.0 - 0.1]
|
|
0.1 G/l [†0.1]
|
|
|
0.1 G/l [†0.1]
|
|
|
0.1 G/l [†0.1]
|
|
|
HĂ€matologie:Differentialblutbild:Basophile (%)
|
0.8 % [<2.0]
|
|
0.7 % [0.0 - 2.0]
|
0 % [0.0 - 2.0]
|
|
1 % [0.0 - 1.0]
|
|
|
1.2 % (+) [0.0 - 1.0]
|
|
|
1.0 % [0.0 - 1.0]
|
|
0.8 % [0.0 - 1.0]
|
0.7 % [0.0 - 1.0]
|
1.0 % [0.0 - 1.0]
|
|
0.7 % [0.0 - 1.0]
|
|
|
0.9 % [0.0 - 1.0]
|
|
|
0.8 % [0.0 - 1.0]
|
|
|
HĂ€matologie:Differentialblutbild:Eosinophile
|
0.39 G/l [<0.40]
|
|
0.2 G/l [0.0 - 0.5]
|
|
|
0.1 G/l [0.0 - 0.4]
|
|
|
0.3 G/l [†0.4]
|
|
|
0.2 G/l [†0.4]
|
0.1 G/l [†0.4]
|
0.2 G/l [†0.4]
|
0.1 G/l [†0.4]
|
0.2 G/L [0.0 - 0.4]
|
|
0.1 G/l [†0.4]
|
|
|
0.2 G/l [†0.4]
|
|
|
0.2 G/l [†0.4]
|
|
|
HĂ€matologie:Differentialblutbild:Eosinophile (%)
|
6.4 % (+) [<4.0]
|
|
2.9 % [0.0 - 6.0]
|
2 % [1.0 - 5.0]
|
|
2 % [0.0 - 4.0]
|
|
|
4.2 % (+) [0.0 - 4.0]
|
|
|
2.5 % [0.0 - 4.0]
|
|
2.8 % [0.0 - 4.0]
|
0.7 % [0.0 - 4.0]
|
2.6 % [0.0 - 4.0]
|
|
1.6 % [0.0 - 4.0]
|
|
|
3.1 % [0.0 - 4.0]
|
|
|
2.3 % [0.0 - 4.0]
|
|
|
HĂ€matologie:Differentialblutbild:Lymphozyten
|
2.1 G/l [1.0-4.0]
|
|
1.55 G/l [1.00 - 4.00]
|
|
|
1.3 G/l [1.0 - 4.0]
|
|
|
1.4 G/l [1 - 4]
|
|
|
1.2 G/l [1 - 4]
|
1.2 G/l [1 - 4]
|
1.4 G/l [1 - 4]
|
1.0 G/l [1 - 4]
|
2.2 G/L [1.0 - 4.0]
|
|
1.4 G/l [1 - 4]
|
|
|
1.5 G/l [1 - 4]
|
|
|
1.6 G/l [1 - 4]
|
|
|
HĂ€matologie:Differentialblutbild:Lymphozyten (%)
|
35 % [25-40]
|
|
22.4 % (-) [25.0 - 40.0]
|
22 % (-) [25.0 - 40.0]
|
|
24 % (-) [25.0 - 40.0]
|
|
|
22.0 % (-) [25.0 - 40.0]
|
|
|
20.5 % (-) [25.0 - 40.0]
|
|
23.1 % (-) [25.0 - 40.0]
|
8.9 % (-) [25.0 - 40.0]
|
23.9 % (-) [25.0 - 40.0]
|
|
16.4 % (-) [25.0 - 40.0]
|
|
|
19.8 % (-) [25.0 - 40.0]
|
|
|
20.1 % (-) [25.0 - 40.0]
|
|
|
HĂ€matologie:Differentialblutbild:Monozyten
|
0.6 G/l [<1.2]
|
|
0.6 G/l [0.1 - 0.7]
|
|
|
0.4 G/l [0.0 - 1.2]
|
|
|
0.6 G/l [0.2 - 1.2]
|
|
|
0.5 G/l [0.2 - 1.2]
|
0.5 G/l [0.2 - 1.2]
|
0.6 G/l [0.2 - 1.2]
|
0.4 G/l [0.2 - 1.2]
|
0.8 G/L [0.0 - 1.2]
|
|
0.6 G/l [0.2 - 1.2]
|
|
|
0.5 G/l [0.2 - 1.2]
|
|
|
0.6 G/l [0.2 - 1.2]
|
|
|
HĂ€matologie:Differentialblutbild:Monozyten (%)
|
9 % [<12]
|
|
8.1 % [1.0 - 10.0]
|
7 % [2.0 - 10.0]
|
|
8 % [0.0 - 12.0]
|
|
|
9.2 % [2.0 - 12.0]
|
|
|
8.3 % [2.0 - 12.0]
|
|
9.1 % [2.0 - 12.0]
|
4.1 % [2.0 - 12.0]
|
8.1 % [0.0 - 12.0]
|
|
6.5 % [2.0 - 12.0]
|
|
|
6.9 % [2.0 - 12.0]
|
|
|
7.6 % [2.0 - 12.0]
|
|
|
HĂ€matologie:Differentialblutbild:Neutrophile
|
2.9 G/l [2.0-7.5]
|
|
4.6 G/l [1.9 - 8.0]
|
|
|
|
|
|
|
|
|
|
|
|
|
6.0 G/L [2.0 - 7.5]
|
|
|
|
|
|
|
|
|
|
|
HĂ€matologie:Differentialblutbild:Neutrophile (%)
|
49 % (-) [50-75]
|
|
65.9 % [50.0 - 70.0]
|
|
|
|
|
|
|
|
|
|
|
|
|
64.4 % [50.0 - 75.0]
|
|
|
|
|
|
|
|
|
|
|
HÀmatologie:Differentialblutbild:Neutrophilen-Lymphozyten-VerhÀltnis (NLR)
|
1.38 [1.0 - 3.0]
|
|
2.97 [1.0 - 3.0]
|
|
|
|
|
|
|
|
|
|
|
|
|
2.73 [1.0 - 3.0]
|
|
|
|
|
|
|
|
|
|
|
HĂ€matologie:Differentialblutbild:Segmentkernige
|
|
|
|
|
|
3.6 G/l [2.0 - 7.5]
|
|
|
4.0 G/l [2 - 7.5]
|
|
|
4.0 G/l [2 - 7.5]
|
3.8 G/l [2 - 7.5]
|
3.9 G/l [2 - 7.5]
|
9.2 G/l (+) [2 - 7.5]
|
|
|
6.5 G/l [2 - 7.5]
|
|
|
5.3 G/l [2 - 7.5]
|
|
|
5.5 G/l [2 - 7.5]
|
|
|
HĂ€matologie:Differentialblutbild:Segmentkernige (%)
|
|
|
|
67 % [50.0 - 70.0]
|
|
66 % [50.0 - 75.0]
|
|
|
62.3 % [50.0 - 75.0]
|
|
|
67.2 % [50.0 - 75.0]
|
|
63.9 % [50.0 - 75.0]
|
85.6 % (+) [50.0 - 75.0]
|
|
|
74.8 % [50.0 - 75.0]
|
|
|
68.9 % [50.0 - 75.0]
|
|
|
69.2 % [50.0 - 75.0]
|
|
|
HĂ€matologie:Differentialblutbild:Stabkernige
|
|
|
|
|
|
0.0 G/l [0.0 - 0.5]
|
|
|
0.1 G/l [†0.5]
|
|
|
0.0 G/l [†0.5]
|
0.0 G/l [†0.5]
|
0.0 G/l [†0.5]
|
0.0 G/l [†0.5]
|
|
|
0.0 G/l [†0.5]
|
|
|
0.0 G/l [†0.5]
|
|
|
0.0 G/l [†0.5]
|
|
|
HĂ€matologie:Differentialblutbild:Stabkernige (%)
|
|
|
|
2 % [0.0 - 5.0]
|
|
0 % [0.0 - 5.0]
|
|
|
1.1 % [0.0 - 5.0]
|
|
|
0.5 % [0.0 - 5.0]
|
|
0.3 % [0.0 - 5.0]
|
0.4 % [0.0 - 5.0]
|
|
|
0.5 % [0.0 - 5.0]
|
|
|
0.4 % [0.0 - 5.0]
|
|
|
0.3 % [0.0 - 5.0]
|
|
|
Immunologie:IgA
|
|
|
|
|
|
|
|
|
|
|
|
|
234 mg/dl [70 - 400]
|
|
|
|
|
247 mg/dl [70 - 400]
|
|
|
|
|
|
|
|
|
Immunologie:IgE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
877 IU/ml (+) [< 100]
|
|
|
|
928 IU/ml (+) [<100]
|
|
|
|
|
|
871 IU/ml (+) [< 100]
|
|
|
Immunologie:IgG
|
|
|
|
|
|
|
|
|
|
|
|
|
1283 mg/dl [700 - 1600]
|
|
|
|
|
1294 mg/dl [700 - 1600]
|
|
|
|
|
|
|
|
|
Immunologie:IgM
|
|
|
|
|
|
|
|
|
|
|
|
|
95 mg/dl [40 - 230]
|
|
|
|
|
97 mg/dl [40 - 230]
|
|
|
|
|
|
|
|
|
Infektionsdiagnostik:HBV c-AK
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Infektionsdiagnostik:HBV s-AG
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Infektionsdiagnostik:HCV-AK
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:ALAT (GPT)
|
|
|
12 U/l [0 - 49]
|
120 U/l (+) [< 50]
|
|
17 U/l [< 50]
|
|
|
18 U/l [< 50]
|
|
|
29 U/l [< 50]
|
31 U/l [< 50]
|
|
22 U/l [< 50]
|
|
|
|
|
|
27 U/l [< 50]
|
|
|
|
17 U/l [< 50]
|
|
Klinische Chemie:ASAT (GOT)
|
|
|
22 U/l [0 - 49]
|
64 U/l (+) [< 50]
|
|
20 U/l [< 50]
|
|
|
23 U/l [< 50]
|
|
|
23 U/l [< 50]
|
25 U/l [< 50]
|
|
26 U/l [< 50]
|
|
|
|
|
|
26 U/l [< 50]
|
|
|
|
23 U/l [< 50]
|
|
Klinische Chemie:Albumin
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
49.0 g/L [35 - 52]
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Alkalische Phosphatase
|
|
|
61 U/l [30 - 120]
|
62 U/l [< 129]
|
|
79 U/l [< 129]
|
|
|
82 U/l [40 - 129]
|
|
|
|
|
|
82 U/l [40 - 129]
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Alpha Amylase
|
|
|
|
34 U/l [< 100]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Anorganisches Phosphat
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.16 mmol/L [0.81 - 1.45]
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:BUN
|
|
|
10.6 mg/dl [7.9 - 20.1]
|
|
10 mg/dl [6 - 20]
|
|
|
|
6.7 mg/dl [6.0 - 20]
|
|
|
13 mg/dl [6.0 - 20]
|
|
|
18 mg/dl [6.0 - 20]
|
|
|
|
|
|
12 mg/dl [6.0 - 20]
|
|
|
|
|
|
Klinische Chemie:Bilirubin
|
|
|
1.77 mg/dl (+) [0.30 - 1.20]
|
|
|
|
|
|
1.8 mg/dl (+) [< 1.2]
|
|
|
1.8 mg/dl (+) [< 1.2]
|
|
|
1.7 mg/dl (+) [< 1.2]
|
|
|
|
|
|
1.3 mg/dl (+) [< 1.2]
|
|
|
|
|
|
Klinische Chemie:Bilirubin gesamt
|
|
|
|
1.55 mg/dl (+) [< 1.2]
|
|
1.8 mg/dl (+) [< 1.2]
|
|
|
|
|
|
|
|
|
|
1.0 mg/dL [0.0 - 1.2]
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Blutsenkung 1h
|
4 mm/1h [<10]
|
|
3 mm [1 - 10]
|
|
|
|
|
|
|
|
|
2 mm/h [†15]
|
|
|
|
|
|
|
2 mm/h [<= 15]
|
|
2 mm/h [†15]
|
|
|
|
|
|
Klinische Chemie:Blutsenkung 2h
|
6 mm/2h [<20]
|
|
|
|
|
|
|
|
|
|
|
8 mm/h [†32]
|
|
|
|
|
|
|
8 mm/h [<= 32]
|
|
8 mm/h [†32]
|
|
|
|
|
|
Klinische Chemie:Blutzucker
|
|
|
|
95 mg/dl [60 - 110]
|
|
99 mg/dl [60 - 110]
|
|
|
89 mg/dl [60 - 106]
|
|
|
90 mg/dl [60 - 106]
|
|
|
87 mg/dl [60 - 106]
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:CK
|
|
|
|
82 U/l [39 - 308]
|
|
99 U/l [<190]
|
|
|
133 U/l [< 190]
|
|
|
|
|
|
165 U/l [< 190]
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:CRP
|
<0.3 mg/dl [<0.5]
|
|
|
|
|
|
|
|
|
|
|
<0.06 mg/dl [< 0.50]
|
<0.06 mg/dl [< 0.50]
|
|
<0.06 mg/dl [< 0.50]
|
0.04 mg/dL [< 0.5]
|
|
|
|
|
0.13 mg/dl [< 0.50]
|
|
|
|
|
|
Klinische Chemie:Calcium
|
|
|
2.54 mmol/l [2.2 - 2.65]
|
|
|
|
|
|
|
|
|
|
2.4 mmol/l [2.2 - 2.5]
|
|
2.5 mmol/l [2.2 - 2.5]
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Chlorid
|
|
|
|
105 mmol/l [95 - 107]
|
|
104 mmol/l [95 - 107]
|
|
|
102 mmol/l [98 - 107]
|
|
|
|
102 mmol/l [98 - 107]
|
|
101 mmol/l [98 - 107]
|
99 mmol/L [98 - 107]
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Cholesterin
|
161 mg/dl [0-200]
|
|
156 mg/dl [100 - 199]
|
139 mg/dl [< 200]
|
|
133 mg/dl [< 200]
|
|
|
131 mg/dl [< 200]
|
|
|
138 mg/dl [< 200]
|
134 mg/dl [< 200]
|
|
136 mg/dl [< 200]
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Cholesterin HDL
|
68 mg/dl [>40]
|
|
|
68 mg/dl [> 55]
|
|
68 mg/dl [> 55]
|
|
|
67 mg/dl [> 40]
|
|
|
66 mg/dl [> 40]
|
65 mg/dl [> 40]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Cholesterin LDL
|
85 mg/dl [< 130]
|
|
|
60 mg/dl [< 130]
|
|
56 mg/dl [< 130]
|
|
|
55 mg/dl [< 130]
|
|
|
63 mg/dl [< 130]
|
60 mg/dl [< 130]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Cholesterin LDL/HDL
|
|
|
|
|
|
0.8 - [< 3.7]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Cholesterin/HDL
|
|
|
|
2.0 [< 5.0]
|
|
2.0 - [< 5.0]
|
|
|
2.0 - [< 3.5]
|
|
|
2.1 [< 3.5]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Cholesterin/HDL-Cholesterin Ratio
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.0 [< 3.5]
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Cholesterin/HDL-Ratio
|
|
|
2.6 [0.0 - 4.0]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Cholinesterase
|
|
|
|
8.8 kU/l [5.3 - 12.9]
|
|
9.9 kU/l [5.3 - 12.9]
|
|
|
8722 U/l [> 5320]
|
|
|
|
|
|
8623 U/l [> 5320]
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Eisen
|
|
|
89 ”g/dl [70 - 180]
|
|
|
132 ”g/dl [59 - 158]
|
|
|
85 ”g/dl [33 - 193]
|
|
|
149 ”g/dl [33 - 193]
|
|
|
117 ”g/dl [33 - 193]
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:EiweiĂ, gesamt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
76.4 g/L [64 - 83]
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Ferritin
|
|
|
|
|
|
80 ng/ml [30 - 400]
|
|
|
102 ng/ml [30 - 400]
|
|
|
|
|
|
74 ng/ml [30 - 400]
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:GFR
|
|
|
|
|
|
97.8 ml/min [> 75]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:GFR (CKD-EPI)
|
|
|
|
|
|
|
|
|
86 ml/min [75 - 200]
|
|
|
86 ml/min [75 - 200]
|
|
|
96 ml/min [75 - 200]
|
|
|
|
|
|
85 ml/min [â„ 75]
|
|
|
|
|
|
Klinische Chemie:GFR/1.7m2KO (MDRD)
|
|
|
>60 ml/min [60 - 200]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Gamma-GT
|
|
|
13 U/l [0 - 54]
|
11 U/l [5 - 60]
|
|
|
|
|
9 U/l [< 61]
|
|
|
9 U/l [< 61]
|
10 U/l [< 61]
|
|
7 U/l [< 61]
|
|
|
|
|
|
8 U/l [< 61]
|
|
|
|
9 U/l [< 61]
|
|
Klinische Chemie:GlomerulÀre Filtrationsrate
|
|
|
|
|
103 ml/min
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Glucose
|
|
|
94 mg/dl [70 - 100]
|
|
|
|
|
|
|
|
|
|
|
|
|
99 mg/dL [74 - 109]
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:HDL-Cholesterin
|
|
|
61 mg/dl [60 - 180]
|
|
|
|
|
|
|
|
|
|
|
|
69 mg/dl [> 40]
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Harnstoff
|
|
|
|
|
21 mg/dl [13 - 43]
|
15 mg/dl [13 - 43]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Harnstoff - N
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.7 mg/dL [6 - 20]
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:HarnsÀure
|
5.6 mg/dl [3.4-7.0]
|
|
5.0 mg/dl [3.5 - 7.2]
|
|
5.2 mg/dl [3.4 - 7.0]
|
5.4 mg/dl [3.4 - 7.0]
|
|
|
5.4 mg/dl [3.4 - 7]
|
|
|
4.9 mg/dl [3.4 - 7]
|
|
|
|
4.4 mg/dL [3.4 - 7.0]
|
|
|
|
|
3.5 mg/dl [3.4 - 7]
|
|
|
|
|
|
Klinische Chemie:HbA1c
|
|
|
|
|
|
|
|
|
|
|
|
|
4.8 % [< 6.5]
|
|
5.0 % [< 6.5]
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:HbA1c (IFCC)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31 mmol/mol [< 47]
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Kalium
|
|
|
5.2 mmol/l (+) [3.5 - 5.1]
|
4.7 mmol/l [3.5 - 5.5]
|
|
4.6 mmol/l [3.5 - 5.5]
|
|
|
4.6 mmol/l [3.5 - 5.5]
|
|
|
4.6 mmol/l [3.5 - 5.5]
|
4.5 mmol/l [3.5 - 5.5]
|
|
5.5 mmol/l [3.5 - 5.5]
|
3.97 mmol/L [3.5 - 5.1]
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Kalzium
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.38 mmol/L [2.15 - 2.50]
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Kreatinin
|
|
|
1.0 mg/dl [0.67 - 1.17]
|
|
0.9 mg/dl [0.5 - 1.2]
|
1.0 mg/dl [0.5 - 1.2]
|
|
|
1.1 mg/dl [< 1.2]
|
|
|
1.1 mg/dl [< 1.2]
|
|
|
1.0 mg/dl [< 1.2]
|
0.94 mg/dL [0.70 - 1.20]
|
|
|
|
|
1.1 mg/dl [< 1.2]
|
|
|
|
|
|
Klinische Chemie:LDH
|
|
|
|
177 U/l [135 - 225]
|
|
160 U/l [135 - 225]
|
|
|
173 U/l [135 - 225]
|
|
|
200 U/l [135 - 225]
|
|
171 U/l [134 - 257]
|
|
|
|
|
|
|
187 U/l [134 - 257]
|
|
|
|
181 U/l [134 - 257]
|
|
Klinische Chemie:LDL-Cholesterin
|
|
|
94 mg/dl [0 - 99]
|
|
|
|
|
|
|
|
|
|
|
|
55 mg/dl [< 130]
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Lipase
|
|
|
|
41 U/l [< 78]
|
|
48 U/l [< 78]
|
|
|
50 U/l [13 - 60]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
51 U/l [13 - 60]
|
|
Klinische Chemie:Magnesium
|
|
|
|
|
|
|
|
|
|
|
|
|
0.8 mmol/l [0.7 - 1.1]
|
|
0.8 mmol/l [0.7 - 1.1]
|
0.92 mmol/L [0.66 - 1.07]
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Natrium
|
|
|
|
142 mmol/l [130 - 146]
|
|
142 mmol/l [130 - 146]
|
|
|
140 mmol/l [136 - 145]
|
|
|
139 mmol/l [136 - 145]
|
140 mmol/l [136 - 145]
|
|
142 mmol/l [136 - 145]
|
137 mmol/L [136 - 145]
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:NĂŒchtern-Blutzucker
|
97 mg/dl [<100]
|
|
|
|
|
|
|
|
|
|
|
|
90 mg/dl [60 - 106]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Pankreas-Amylase
|
|
|
|
|
|
33 U/l [13 - 53]
|
|
|
32 U/l [13 - 53]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38 U/l [13 - 53]
|
|
Klinische Chemie:Phosphat
|
|
|
|
|
|
|
|
|
|
|
|
|
0.8 mmol/l [0.80 - 1.50]
|
|
1.0 mmol/l [0.80 - 1.50]
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Transferrin
|
|
|
|
|
|
305 mg/dl [200 - 360]
|
|
|
276 mg/dl [200 - 360]
|
|
|
|
|
|
289 mg/dl [200 - 360]
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:TransferrinsÀttigung
|
|
|
|
|
|
31 % [16 - 45]
|
|
|
22 % [16 - 45]
|
|
|
|
|
|
29 % [16 - 45]
|
|
|
|
|
|
|
|
|
|
|
|
Klinische Chemie:Triglyceride
|
39 mg/dl [0-150]
|
|
40 mg/dl [0 - 149]
|
53 mg/dl [< 150]
|
|
44 mg/dl [< 150]
|
|
|
44 mg/dl [< 150]
|
|
|
45 mg/dl [< 150]
|
44 mg/dl [< 150]
|
|
58 mg/dl [< 150]
|
50 mg/dL [< 150]
|
|
|
|
|
|
|
|
|
|
|
Laborwerte:Blutzucker_1_Std
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
88 mg/dl (?) [Gestörte Glukosetoleranz: 140 - 199, Manifester Diabetes mellitus: ℠200]
|
|
|
|
|
|
|
|
|
|
Laborwerte:Blutzucker_2_Std
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
80 mg/dl [< 140]
|
|
|
|
|
|
|
|
|
|
Laborwerte:Blutzucker_nĂŒchtern
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
94 mg/dl [< 100]
|
|
|
|
|
|
|
|
|
|
Laborwerte:Harnzucker_1_Std
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 mg/dl [< 25]
|
|
|
|
|
|
|
|
|
|
Laborwerte:Harnzucker_2_Std
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 mg/dl [< 25]
|
|
|
|
|
|
|
|
|
|
Laborwerte:Harnzucker_nĂŒchtern
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6.0 mg/dl [< 16.5]
|
|
|
|
|
|
|
|
|
|
Leberwerte:Gamma-GT
|
11 U/l [<60]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lymphozyten-Subpopulationen absolut:B-Zellen (CD19+)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
134 /”l [110 - 530]
|
|
|
|
|
|
|
|
|
|
|
|
|
Lymphozyten-Subpopulationen absolut:CD4/CD8-Ratio
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.4 Ratio [0.5 - 3.1]
|
|
|
|
|
|
|
|
|
|
|
|
|
Lymphozyten-Subpopulationen absolut:NK-Zellen (CD56/16+CD3-)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
428 /”l [80 - 510]
|
|
|
|
|
|
|
|
|
|
|
|
|
Lymphozyten-Subpopulationen absolut:NKT-Zellen (CD56/16+CD3+)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
116 /”l [†400]
|
|
|
|
|
|
|
|
|
|
|
|
|
Lymphozyten-Subpopulationen absolut:T-Helferzellen (CD4+)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
496 /”l [360 - 1350]
|
|
|
|
|
|
|
|
|
|
|
|
|
Lymphozyten-Subpopulationen absolut:T-Zellen (CD3+)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
832 /”l [590 - 1990]
|
|
|
|
|
|
|
|
|
|
|
|
|
Lymphozyten-Subpopulationen absolut:T-Zytotoxische Zellen (CD8+)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
204 /”l (-) [280 - 1000]
|
|
|
|
|
|
|
|
|
|
|
|
|
Lymphozyten-Subpopulationen relativ:B-Zellen (CD19+)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9.6 % [7 - 23]
|
|
|
|
|
|
|
|
|
|
|
|
|
Lymphozyten-Subpopulationen relativ:NK-Zellen (CD56/16+CD3-)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30.6 % [5 - 34]
|
|
|
|
|
|
|
|
|
|
|
|
|
Lymphozyten-Subpopulationen relativ:NKT-Zellen (CD56/16+CD3+)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8.3 % [†10]
|
|
|
|
|
|
|
|
|
|
|
|
|
Lymphozyten-Subpopulationen relativ:T-Helferzellen (CD4+)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35.4 % [27 - 59]
|
|
|
|
|
|
|
|
|
|
|
|
|
Lymphozyten-Subpopulationen relativ:T-Zellen (CD3+)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59.4 % [58 - 84]
|
|
|
|
|
|
|
|
|
|
|
|
|
Lymphozyten-Subpopulationen relativ:T-Zytotoxische Zellen (CD8+)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.6 % (-) [19 - 48]
|
|
|
|
|
|
|
|
|
|
|
|
|
Metalle und Spurenelemente:Zink
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98 ”g/dl [60 - 120]
|
|
|
Nierenwerte:GFR (CKD-EPI)
|
|
|
|
|
|
|
|
|
|
|
|
|
86 ml/min [75 - 200]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nierenwerte:GlomFiltrRCockcroft
|
99.56 ml/min [98-156]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nierenwerte:Kreatinin
|
1.0 mg/dl [0.5-1.2]
|
|
|
|
|
|
|
|
|
|
|
|
1.1 mg/dl [< 1.2]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nierenwerte:glomerulÀre Filtrationsrate (MDRD)
|
>60 ml/min (-) [>60]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proteindiagnostik:Albumin
|
|
|
|
|
|
|
|
|
|
42 g/l [35 - 52]
|
48 g/l [35 - 52]
|
|
43 g/l [35 - 52]
|
|
46 g/l [35 - 52]
|
|
|
|
|
|
43 g/l [35 - 52]
|
|
47 g/l [35 - 52]
|
|
|
|
Proteindiagnostik:Albumin (absolut)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43 g/l [35 - 52]
|
|
|
|
|
|
|
|
|
|
|
|
Proteindiagnostik:Albumin rel.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
58.7 % [53.0 - 67.0]
|
|
|
|
|
|
58.2 % [53.0 - 67.0]
|
|
|
|
|
|
Proteindiagnostik:Alpha-1-Globulin rel.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.2 % [3.0 - 5.4]
|
|
|
|
|
|
4.3 % [3.0 - 5.4]
|
|
|
|
|
|
Proteindiagnostik:Alpha-2-Globulin rel.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8.7 % [7.2 - 12.9]
|
|
|
|
|
|
8.6 % [7.2 - 12.9]
|
|
|
|
|
|
Proteindiagnostik:Alpha-Globulin (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.1 g/l [2.1 - 3.6]
|
|
|
|
|
|
3.2 g/l [2.1 - 3.6]
|
|
|
|
|
|
Proteindiagnostik:Alpha-Globulin (2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6.4 g/l [5.0 - 8.9]
|
|
|
|
|
|
6.4 g/l [5.0 - 8.9]
|
|
|
|
|
|
Proteindiagnostik:Beta-1-Globulin rel.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6.6 % [5.0 - 7.1]
|
|
|
|
|
|
6.8 % [5.0 - 7.1]
|
|
|
|
|
|
Proteindiagnostik:Beta-2-Globulin rel.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.4 % [3.7 - 7.1]
|
|
|
|
|
|
5.7 % [3.7 - 7.1]
|
|
|
|
|
|
Proteindiagnostik:Beta-Globulin (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.9 g/l [3.4 - 5.1]
|
|
|
|
|
|
5.0 g/l [3.4 - 5.1]
|
|
|
|
|
|
Proteindiagnostik:Beta-Globulin (2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.0 g/l [2.5 - 5.1]
|
|
|
|
|
|
4.2 g/l [2.5 - 5.1]
|
|
|
|
|
|
Proteindiagnostik:Gamma-Globulin
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12.1 g/l [6.5 - 14.3]
|
|
|
|
|
|
12.1 g/l [6.5 - 14.3]
|
|
|
|
|
|
Proteindiagnostik:Gamma-Globulin rel.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16.4 % [9.9 - 19.5]
|
|
|
|
|
|
16.4 % [9.9 - 19.5]
|
|
|
|
|
|
Proteindiagnostik:Homocystein
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.6 ”mol/l [5.5 - 15]
|
|
|
|
Proteindiagnostik:Totalprotein
|
|
|
|
|
|
|
|
|
|
|
|
|
7.1 g/dl [6.0 - 8.0]
|
|
7.4 g/dl [6.0 - 8.0]
|
|
|
|
|
|
7.4 g/dl [6.0 - 8.0]
|
|
|
|
|
|
Spermiogramm:Ejakulatvolumen
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6.3 ml [> 1.4]
|
|
|
|
|
|
|
Spermiogramm:Leukozyten im Ejakulat
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<1.0
|
|
|
|
|
|
|
Spermiogramm:Morphologie normale Formen
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 % [â„ 4]
|
|
|
|
|
|
|
Spermiogramm:MotilitÀt Gesamt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26 % (-) [â„ 42]
|
|
|
|
|
|
|
Spermiogramm:MotilitÀt Ortsbeweglich
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 %
|
|
|
|
|
|
|
Spermiogramm:MotilitÀt Rasch vorwÀrtsbeweglich
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 % (-) [â„ 30]
|
|
|
|
|
|
|
Spermiogramm:MotilitÀt Unbeweglich
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
74 %
|
|
|
|
|
|
|
Spermiogramm:Rundzellen im Ejakulat
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<5.0
|
|
|
|
|
|
|
Spermiogramm:Spermien Gesamtzahl
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
573.0 Mio [â„ 39.0]
|
|
|
|
|
|
|
Spermiogramm:Spermienkonzentration
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
91.0 Mio/ml [â„ 16.0]
|
|
|
|
|
|
|
Spermiogramm:ph-Wert
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8.2 [â„ 7.2]
|
|
|
|
|
|
|
Stuhlbefund:Stuhl Occ. Blut 3x
|
neg [neg]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tumormarker:PSA
|
|
|
|
|
0.26 ng/ml [< 1.4]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.415 ”g/l [< 1.4]
|
|
|
|
Urindiagnostik:Bilirubin
|
neg [neg]
|
|
negativ
|
|
|
|
|
|
|
|
|
negativ mg/dl [negativ]
|
|
|
negativ mg/dl [negativ]
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:Erythrozyten
|
|
|
|
|
|
|
|
|
|
|
|
negativ Ery /”l [< 18]
|
|
|
negativ Ery /”l [< 18]
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:Glucose
|
|
|
negativ
|
|
|
|
|
|
|
|
|
negativ mg/dl [< 25]
|
|
|
negativ mg/dl [< 25]
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:Harnblutfarbstoff
|
neg Ery/”l [neg]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:Harnsediment
|
v PE v L v a U
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:Harnsediment Beurteilung
|
|
|
|
|
|
|
|
|
|
|
|
unauffÀllig
|
|
|
unauffÀllig
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:HarnweiĂe
|
neg mg/dl [neg]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:Harnzucker
|
neg mg/dl [neg]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:HĂ€moglobin (Ery)
|
|
|
negativ
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:Keton
|
neg mg/dl [neg]
|
|
negativ
|
|
|
|
|
|
|
|
|
negativ mg/dl [< 2]
|
|
|
50 mg/dl (+) [< 2]
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:Leukozyten
|
neg L/”l [neg]
|
|
negativ
|
|
|
|
|
|
|
|
|
negativ Leu /”l [< 10]
|
|
|
negativ Leu /”l [< 10]
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:Nitrit
|
neg [neg]
|
|
negativ
|
|
|
|
|
|
|
|
|
negativ [negativ]
|
|
|
negativ [negativ]
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:SchleimfÀden /US
|
|
|
(++++) massenhaft
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:Spezifisches Gewicht
|
|
|
1031 kg/l (+) [1012 - 1030]
|
|
|
|
|
|
|
|
|
1.022 g/ml [1.012 - 1.030]
|
|
|
1.023 g/ml [1.012 - 1.030]
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:Totalprotein
|
|
|
50 mg/dl (+) [0 - 29]
|
|
|
|
|
|
|
|
|
negativ mg/dl [†30]
|
|
|
negativ mg/dl [†30]
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:Urinfarbe
|
|
|
gelb
|
|
|
|
|
|
|
|
|
gelb
|
|
|
goldgelb
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:UrintrĂŒbung
|
|
|
klar
|
|
|
|
|
|
|
|
|
klar
|
|
|
klar
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:Urobilinogen
|
normal mg/dl [normal]
|
|
normal (0.2-1.0 mg/dl)
|
|
|
|
|
|
|
|
|
negativ mg/dl [< 1]
|
|
|
negativ mg/dl [< 1]
|
|
|
|
|
|
|
|
|
|
|
|
Urindiagnostik:pH
|
5 [5-9]
|
|
6.5 [5.0 - 8.0]
|
|
|
|
|
|
|
|
|
7.0 [5.0 - 9.0]
|
|
|
6.0 [5.0 - 9.0]
|
|
|
|
|
|
|
|
|
|
|
|
Virologie:CMV IgM-AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<5 U/ml (?) [{'negativ': '<18', 'grenzwertig': '18-22', 'positiv': '>22'}]
|
|
|
|
|
|
|
|
|
Virologie:EBV IgG-AK (EBNA-1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<3 U/ml (?) [{'negativ': '<5', 'grenzwertig': '5-20', 'positiv': '>20'}]
|
|
|
|
|
|
|
|
|
Virologie:EBV IgG-AK (VCA)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<10 U/ml (?) [{'negativ': '<20', 'positiv': 'â„20'}]
|
|
|
|
|
|
|
|
|
Virologie:EBV IgM-AK (VCA)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<10 U/ml (?) [{'negativ': '<20', 'grenzwertig': '20-40', 'positiv': '>40'}]
|
|
|
|
|
|
|
|
|
Virologie:HAV-AK IgM
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ [negativ]
|
|
|
|
|
|
|
|
|
Virologie:HBV c-AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ [negativ]
|
|
|
|
|
|
|
|
|
Virologie:HBV s-AG
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ [negativ]
|
|
|
|
|
|
|
|
|
Virologie:HCV-AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ [negativ]
|
|
|
|
|
|
|
|
|
Virologie:HIV-AK/AG (Typ 1+2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
negativ [negativ]
|
|
|
|
|
|
|
|
|
Virologie:SARS-CoV-2 N (Nukleokapsid)-AK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
positiv (!) [negativ]
|
|
|
|
|
|
|
|
|
Vitamine:25-Hydroxy-Vitamin D3
|
12 ng/ml (-) [30-70]
|
|
|
9.0 ng/ml (-) [>= 10]
|
|
45.6 ng/ml [30 - 100]
|
|
|
34 ng/ml [30 - 100]
|
|
|
39 ng/ml [30 - 100]
|
38 ng/ml [30 - 100]
|
|
42 ng/ml [30 - 100]
|
|
|
|
|
|
|
|
|
|
|
|
Vitamine:25-Hydroxy-Vitamin D3-IFCC
|
29 nmol/l (-) [75-175]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vitamine:FolsÀure
|
|
|
|
4.8 ng/ml [2.8 - 32.2]
|
|
9.7 ng/ml [2.8 - 32.2]
|
|
|
7.5 ng/ml [> 2.8]
|
|
|
7.0 ng/ml [> 2.8]
|
3.9 ng/ml [> 2.8]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vitamine:Vitamin B12
|
|
|
|
503 pg/ml [145 - 637]
|
|
466 pg/ml [197 - 771]
|
|
|
576 pg/ml [> 197]
|
|
|
504 pg/ml [> 197]
|
452 pg/ml [> 197]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Zytokine:Interleukin 6 (IL6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
< 2.0 pg/ml [< 3.4]
|
Zytokine:Tumornekrosefaktor alpha (TNF)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20.1 pg/ml (+) [< 8.1]
|